Clinical Trial Update: Impact of NMN Supplementation on CD4+ T Cell Recovery in HIV Patients With Immunological Failure [NA]

View source ↗

Summary

This ClinicalTrials.gov update outlines a study investigating whether nicotinamide mononucleotide (NMN) supplementation can improve CD4+ T cell recovery in HIV …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Human Immunodeficiency Virus Infection

Drugs mentioned

• Nicotinamide Mononucleotide (NMN) (nicotinamide mononucleotide)

Snippet

Sponsor: TriHealth Inc. | Conditions: Human Immunodeficiency Virus | NA | Status: NOT_YET_RECRUITING